Calcipotriol/Betamethason Dermapharm 50 µg/g - 0,5 mg/g ointm.

Country: Belgium

Language: English

Source: AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

Active ingredient:

Calcipotriol Monohydrate 0,052 mg/g - Eq. Calcipotriol 0,05 mg/g; Betamethasone Dipropionate 0,643 mg/g - Eq. Betamethasone 0,5 mg/g

Available from:

Dermapharm AG

ATC code:

D05AX52

INN (International Name):

Calcipotriol Monohydrate; Betamethasone Dipropionate

Dosage:

50 µg/g - 0,5 mg/g

Pharmaceutical form:

Ointment

Composition:

Calcipotriol Monohydrate 0.052 mg/g; Betamethasone Dipropionate 0.643 mg/g

Administration route:

Cutaneous use

Therapeutic area:

Calcipotriol, Combinations

Product summary:

CTI code: 543217-07 - Pack size: 100 g (2 x 50 g) - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 543217-08 - Pack size: 120 g - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 543217-09 - Pack size: 120 g (2 x 60 g) - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 543217-03 - Pack size: 35 g - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 543217-04 - Pack size: 50 g - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 543217-05 - Pack size: 60 g - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 543217-06 - Pack size: 100 g - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 543217-01 - Pack size: 15 g - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 543217-02 - Pack size: 30 g - Commercialisation status: NO - Delivery mode: Medical prescription

Authorization status:

Commercialised: No

Authorization date:

2019-07-02